ALGS (ALGS) Stock Price & Analysis
ALGS (ALGS) rose 0.00% to USD 4.08 as of July 25, 2026 at 11:58 UTC, according to Nexqual real-time market data.
ALGS last closed at USD 4.08; the session ranged USD 4.01–4.81 on volume of 201,814 shares. Market capitalization is —, with a 52-week range of USD 4–13.69 (NCM). Source: Nexqual, July 25, 2026 at 11:58 UTC.
Key Statistics (as of July 25, 2026 at 11:58 UTC)
| Price | USD 4.08 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 4.08 |
| Open | USD 4.08 |
| Day Range | USD 4.01 – 4.81 |
| 52-Week Range | USD 4 – 13.69 |
| Volume | 201,814 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (ALGS)
Nexqual's technical model rates ALGS "SELL" based on 3 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 11:58 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 29.5 (oversold) |
| vs SMA50 | Below (USD 5.57) |
| MACD | -0.23 (negative) |
From ALGS's Latest SEC 10-K Filing (filed 2026-03-05)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ANNX | Annexon, Inc. | USD 5.22 | ▼ 0.19% |
| PMVP | PMV Pharmaceuticals, Inc. | USD 1.24 | ▼ 6.77% |
| ALXO | ALX Oncology Holdings Inc. | USD 2.03 | ▲ 0.5% |
| FHTX | Foghorn Therapeutics Inc. | USD 4.85 | ▼ 6.91% |
| PASG | Passage Bio, Inc. | USD 4.94 | ▲ 0.41% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 11:58 UTC. This page is informational and not investment advice.